Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Sussing out a new alliance
March 2019
SHARING OPTIONS:

LAUSANNE, Switzerland & SHANGHAI—AC Immune SA and WuXi Biologics teamed up in recent months under the umbrella of an exclusive strategic collaboration focused on the discovery, development and manufacturing of biologics. The companies inked a memorandum of understanding for a preferred partnership that grants AC Immune access to WuXi Biologics’ platforms in manufacturing and supplying traditional and novel New Biological Entities against CNS disorders. WuXi will become a preferred partner for AC Immune for bioprocess development and manufacturing. The agreement also covers the potential use of AC Immune’s platform to treat non-CNS diseases, and the potential for WuXi Vaccines, the vaccine arm of WuXi Biologics, to apply AC Immune’s vaccine portfolio in China.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.